Stock HBMK HUBEI MINKANG PHARMACEUTICAL LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Hubei Minkang Pharmaceutical Ltd.

Equities

HBMK

US44352W1018

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Hubei Minkang Pharmaceutical Ltd cancelled the acquisition of 51% stake in Henan Wanlong Pharmaceutical Co., Ltd.
CI
Hubei Minkang Pharmaceutical Ltd. Announces Management Changes
CI
Hubei Minkang Pharmaceutical Ltd cancelled the acquisition of 51% stake in Hubei Merryclin Pharmaceuticals Co., Ltd.
CI
Hubei Minkang Pharmaceutical Ltd announced that it has received $0.79 million in funding.
CI
Hubei Minkang Pharmaceutical Ltd signed a memorandum of understanding to acquire up to 51% stake in Hubei Merryclin Pharmaceuticals Co., Ltd.
CI
Hubei Minkang Pharmaceutical Ltd signed a memorandum of understanding to acquire 51% stake in Henan Wanlong Pharmaceutical Co., Ltd.
CI
Hubei Minkang Pharmaceutical Ltd will Change its Ticker to HBMK from HBMK.E
CI
Hubei Minkang Pharmaceutical Ltd will Change its Ticker to HBMKE from HBMK
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HBMK Stock
  4. News Hubei Minkang Pharmaceutical Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW